Objective
Through binding to folate receptor-β (FR-β), the new 99mTc–EC20 (Etarfolatide) imaging technique detects activated but not resting macrophages in vivo. The goal of this study was to investigate macrophage-related inflammation in osteoarthritis (OA).
Methods
Twenty-five individuals (50 knees) with symptomatic OA of at least one knee underwent SPECT-CT imaging of both knees and planar imaging of the whole body after injection of Etarfolatide. Scans and knee radiographs were scored blinded to clinical information including knee and other joint site pain severity. Measures of association controlled for age, gender, BMI and employed repeated measures to adjust for correlation between knees.
Design
Activated macrophages were present in the majority (76%) of knees. The quantity of knee-related macrophages was significantly associated with knee pain severity (R=0.60, p<0.0001) and radiographic knee OA severity including joint space narrowing (R=0.68, p=0.007), and osteophyte (R=0.66, p=0.001). Macrophages were also localized to joints commonly affected by OA including hand finger joints (12%), thumb bases (28%), shoulders (26%), great toes (18%) and ankles (12%). The presence of joint pain at fingers, wrists, ankles and great toes was significantly positively associated with presence of activated macrophages at these sites (p<0.0001–0.04).
Conclusions
This study provides the first direct in vivo evidence for macrophage involvement in OA in a substantial proportion of human knees. The association of quantity of activated macrophages with radiographic knee OA severity and joint symptoms suggests that drugs targeting macrophages and macrophage-associated inflammatory pathways may have the potential to be both symptom and structure modifying.
To assess the safety, tolerability, and pharmacology of LY3023703, a microsomal prostaglandin E synthase 1 (mPGES1) inhibitor, a multiple ascending dose study was conducted. Forty-eight subjects received LY3023703, celecoxib (400 mg), or placebo once daily for 28 days. Compared with placebo, LY3023703 inhibited ex vivo lipopolysaccharide-stimulated prostaglandin E2 (PGE2 ) synthesis 91% and 97% on days 1 and 28, respectively, after 30-mg dosing, comparable to celecoxib's effect (82% inhibition compared to placebo). Unlike celecoxib, which also inhibited prostacyclin synthesis by 44%, LY3023703 demonstrated a maximal increase in prostacyclin synthesis of 115%. Transient elevations of serum aminotransferase were observed in one subject after 30-mg LY3023703 dosing (10× upper limit of normal (ULN)), and one subject after 15-mg dosing (about 1.5× ULN). Results from this study suggest that mPGES1 inhibits inducible PGE synthesis without suppressing prostacyclin generation and presents a novel target for inflammatory pain.
8pm). To characterize the statistical properties of the time series of pain ratings, the means of the pain ratings in three blocks were calculated and compared by one way analysis of covariance. As well, fractal dimension, D, was calculated using rescaled range analysis to characterize the OA participants' pain fluctuations. Results: Thirty-two individuals participated in the study (18 females, age (mean, standard deviation) 59.7 AE6.5 yr; 10 males, 55.3AE6.7 yr). As shown in Figure A, there is no significant difference among the three blocks of time for the mean rating of pain. Figure B displays the distribution of fractal dimension, D. calculated for each individual's mean daily pain intensity. The mean fractal dimension, D, for the population is 1.65AE0.04, which signifies an anti-persistent pain time series. Conclusions: This is the first analysis to characterize the fractal dimension of OA pain. The finding of anti-persistent time series means that on average more intense pain is followed by lesser pain, a finding very similar to that reported for chronic low back pain and in contrast to both purely neuropathic pain and acute pain. Whereas these previous studies were over short time periods, this study suggests that power law scaling can be preserved for much longer periods of time (weeks or months), which is significant for clinical application. The anti-persistent pattern of pain is consistent with the concept of central pain processes activated to modulate peripheral pain input in OA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.